Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Bioequivalence Study of Perampanel Tablets 10 mg [Phase 1]
Phase 1 bioequivalence study of 10 mg perampanel tablets has completed.
-
FDA approval · 2024-06-07FDA Approved: MOTPOLY XR — Supplemental Application (Aucta Pharmaceuticals, Inc.)
FDA approved a supplemental application for MOTPOLY XR (lacosamide) from Aucta Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Perampanel Titration and Cognitive Effects [Phase 4]
Phase 4 trial update evaluating perampanel titration and cognitive effects in epilepsy. The study was terminated with results posted.
-
FDA approval · 2024-06-05FDA Approved: LAMOTRIGINE — Supplemental Application (Yiling Pharmaceutical, Inc.)
FDA approved Yiling Pharmaceutical's supplemental application to market Lamotrigine Extended-Release, a lamotrigine product.
-
FDA approval · 2024-06-04FDA Approved: BRIVARACETAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for brivaracetam from Aurobindo Pharma Limited. This enables the marketing of a generic brivaracetam…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Clinical Outcomes of Pregnant Individuals With Epilepsy - Prospective Study
A prospective study assessing clinical outcomes of pregnant individuals with epilepsy; currently recruiting to evaluate maternal and fetal o…
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies [Phase 2]
A Phase 2 study evaluating MGCND00EP1 as an add-on therapy for resistant epilepsy in children and adolescents has been withdrawn. No results…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: The Lullaby Project as a Musical Intervention for Pregnant Individuals With Epilepsy [NA]
The Lullaby Project is a non-pharmacologic musical intervention studied in pregnant individuals with epilepsy, and the trial is currently re…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center [NA]
Recruitment is ongoing for a benzodiazepine study addressing seizure clusters at a major Mexican neurological center.
-
FDA approval · 2024-05-29FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Gabapentin submitted by Amneal Pharmaceuticals LLC under ANDA202024.
-
FDA approval · 2024-05-29FDA Approved: LEVETIRACETAM — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for levetiracetam granules from Granules Pharmaceuticals Inc., adding a new formulation to the produ…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Effects of Low Glycemic Index Diet in Children With Drug-resistant Epilepsy [NA]
A completed clinical trial evaluated the effects of a low glycemic index diet on children with drug-resistant epilepsy, examining outcomes r…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: fMRI Guided TMS Enhancement of Associative Memory Networks [NA]
A terminated clinical trial evaluating fMRI-guided transcranial magnetic stimulation to enhance associative memory networks in epilepsy, wit…
-
FDA approval · 2024-05-24FDA Approved: CLOBAZAM — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for CLOBAZAM filed by Bionpharma Inc., confirming an additional approval for this clobazam produ…
-
FDA approval · 2024-05-24FDA Approved: LACOSAMIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a lacosamide generic from Macleods Pharmaceuticals Limited under an Original Application (ANDA 208466).
-
FDA approval · 2024-05-17FDA Approved: EPRONTIA — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for EPRONTIA (topiramate) submitted by Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants [Phase 1, Phase 2]
This entry reports the completion of the Phase 1/2 trial Stopping TSC Onset and Progression 2, which studied epilepsy prevention in infants …
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Yoga and Aerobic Exercise in Epilepsy [NA]
A completed clinical trial evaluating yoga and aerobic exercise for people with epilepsy and seizures.
-
CLINICAL_TRIALS other · 2024-05-16Clinical Trial Update: A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures [NA]
This entry notes a clinical trial evaluating a room-temperature atomic magnetrode system for telemetry of epileptic seizures, with recruitme…
-
FDA approval · 2024-05-15FDA Approved: ACETAZOLAMIDE — Supplemental Application (Lifestar Pharma LLC)
FDA has approved a supplemental application for acetazolamide submitted by Lifestar Pharma LLC.
-
FDA label_change · 2024-05-15FDA Approved: CLOBAZAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for CLOBAZAM (clobazam) from Aurobindo Pharma Limited, updating the existing product through a suppl…
-
FDA approval · 2024-05-15FDA Approved: LACOSAMIDE ORAL SOLUTION — Original Application (Chartwell RX, LLC)
FDA approved a generic lacosamide oral solution from Chartwell RX, LLC under an original ANDA. Lacosamide is used as adjunctive therapy for …
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Motivational Interviewing in Adolescents With Epilepsy [NA]
A clinical trial update notes that enrollment by invitation is ongoing for a study on motivational interviewing in adolescents with epilepsy…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Treating Postictal Symptoms Using Ibuprofen and Nifedipine [Phase 2]
A Phase 2 clinical trial sponsored by the University of Calgary is evaluating the combination of ibuprofen and nifedipine to treat postictal…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)
Cannabidiol Expanded Access program for drug-resistant pediatric epilepsy is available.